Search results for: 'biologics particul analysis'

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

The growth of digital tools and technologies has created new business models for the automotive industry. Today's automotive OEMs are shifting from selling cars to providing mobility solutions by exploring opportunities in several markets, such as electric vehicles, connected and autonomous mobility, and others, to create revenue opportunities. Thi...

30 Oct 2015  |  Europe  |  Market Research

Comparative Analysis of Automotive Original Equipment Manufacturers' Powertrain Strategies for Euro 7 Compliance

Focus will be on Particulate Matter Number and On-board Diagnostics

Infographics

×

This research service provides a detailed analysis of how European automotive original equipment manufacturers (OEMs) are expected to comply with Euro 7 emission reduction standards. It delves into spending needed to create a compact and strong aftertreatment package. A technology road map will provide insight about expected modifications of gasoli...

This research service provides an overview of the automotive aftermarket in China, focusing on the mainland. The study covers the business snapshots of the automotive aftermarket, including growth drivers, growth restraints, aftermarket regulations, aftermarket trends, VIO overview, new and used vehicle sales, VIO breakdown by age group, automoti...

The aim of the study is to research, analyse, and forecast the size of and the trends in the European automotive OES channel from 2015 to 2022. As older cars migrate to the independent aftermarket due to an ageing vehicle parc in Europe, OEMs have to strategise their aftersales programmes to maintain their market share (estimated at 38.0% in 2015)....

This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented ...

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...

06 Mar 2024  |  Global  |  Market Research

Growth Opportunities in the Farm-to-Fork Cold Supply Chain

A Comprehensive Analysis of Key Trends and Technologies

Infographics

×

The farm-to-fork (F2F) industry encompasses every stage that food passes through before it ends up on the consumer s tables. These stages include agricultural production, intermediate production, and retail trade and services. This study focuses on the cold supply chain of the F2F ecosystem, which specifically involves refrigerated storage and dist...